The EHR can be touted as a cost-saving, quality-promoting device, though cost-conserving projections have already been debunked and data on quality are blended.2 Although we’ve made improvement in patient safety only by carefully examining our mistakes, somehow the dangers posed by technology are anticipated to right themselves. Second, letting the marketplace form usability assumes that clinicians are the focus on users. So EHRs will be only as good as the quality metrics they’re designed to capture; technology can’t conquer fundamental measurement challenges. We measure a lot of things that have no value to patients, while a lot of what patients do value, including our attention, remains unmeasurable.All individuals were followed until death or the finish of the trial, with censoring of data at the right time an individual underwent transplantation or was lost to follow-up. A Cox model altered for baseline covariates was estimated to determine the association of baseline factors with outcomes. We also performed a post hoc evaluation in which the GFR at the start of dialysis, as approximated with the use of the MDRD equation,25 was compared between the patients in the early-start group and those in the late-begin group. All survival analyses were performed based on the intention-to-treat basic principle.